These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 12927027)
1. ADAM metalloproteases and EGFR signalling. Gee JM; Knowlden JM Breast Cancer Res; 2003; 5(5):223-4. PubMed ID: 12927027 [No Abstract] [Full Text] [Related]
3. Wnt signalling via the epidermal growth factor receptor: a role in breast cancer? Musgrove EA Breast Cancer Res; 2004; 6(2):65-8. PubMed ID: 14979908 [TBL] [Abstract][Full Text] [Related]
4. Studies of EGF-mediated growth control and signal transduction using the MDA-MB-468 human breast cancer cell line. Buick RN; Filmus J; Church J Prog Clin Biol Res; 1990; 354A():179-91. PubMed ID: 2247487 [No Abstract] [Full Text] [Related]
5. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Tuck AB; Hota C; Wilson SM; Chambers AF Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway. Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172 [TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. Maity A; Pore N; Lee J; Solomon D; O'Rourke DM Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786 [TBL] [Abstract][Full Text] [Related]
8. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982 [TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor: receptor and ligand expression in human breast cancer. Murphy LC; Dotzlaw H; Wong MS; Miller T; Mrockowski B; Gong Y; Murphy LJ Semin Cancer Biol; 1990 Oct; 1(5):305-15. PubMed ID: 2103505 [TBL] [Abstract][Full Text] [Related]
11. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells. deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899 [TBL] [Abstract][Full Text] [Related]
12. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Lo HW; Hsu SC; Ali-Seyed M; Gunduz M; Xia W; Wei Y; Bartholomeusz G; Shih JY; Hung MC Cancer Cell; 2005 Jun; 7(6):575-89. PubMed ID: 15950906 [TBL] [Abstract][Full Text] [Related]
18. Type 1 protein tyrosine kinases in breast carcinoma: a review. Suo Z; Nesland JM Ultrastruct Pathol; 2002; 26(3):125-35. PubMed ID: 12184370 [TBL] [Abstract][Full Text] [Related]
19. Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Thomas NB; Hutcheson IR; Campbell L; Gee J; Taylor KM; Nicholson RI; Gumbleton M Breast Cancer Res Treat; 2010 Feb; 119(3):575-91. PubMed ID: 19288272 [TBL] [Abstract][Full Text] [Related]
20. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2. Wu J; Lee C; Yokom D; Jiang H; Cheang MC; Yorida E; Turbin D; Berquin IM; Mertens PR; Iftner T; Gilks CB; Dunn SE Cancer Res; 2006 May; 66(9):4872-9. PubMed ID: 16651443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]